Trehalose improves the movement ability of AβarcDrosophila by restoring the damaged mitochondria

Liangxian Li1,2, Zhiheng Huang1,3, Mingli Wu2

  • 1Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Guilin Medical University, Guilin, 541199, China.

PubMed
Abstract

Insights

Trehalose significantly enhances movement in a Alzheimer's disease (AD) fruit fly model by reducing amyloid-beta (Aβ) levels and restoring mitochondrial function. This study highlights trehalose as a potential therapeutic agent for AD.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Genetics

Background:

  • Amyloid-beta (Aβ) deposition, particularly Aβ42, is a key hallmark of Alzheimer's disease (AD).
  • Developing effective drugs targeting Aβ toxicity has faced significant challenges, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To investigate the therapeutic effects of trehalose on an Alzheimer's disease (AD) fruit fly model expressing arctic mutant Aβ42 (Aβarc).
  • To elucidate the underlying mechanisms by which trehalose influences Aβ toxicity and associated pathologies.

Main Methods:

  • Generation of a *Drosophila melanogaster* model expressing human Aβarc to mimic AD.
  • Administration of trehalose and assessment of locomotor activity (climbing and flight).
  • Biochemical analysis of Aβarc, ATP, and lactate levels; evaluation of mitochondrial structure and function using electron microscopy and functional assays.

Main Results:

  • Trehalose treatment dose-dependently improved the movement ability of Aβarc fruit flies.
  • Trehalose reduced Aβarc and lactate levels while increasing ATP content in both the brain and thorax.
  • Significant restoration of mitochondrial structure and function was observed in trehalose-treated Aβarc flies.

Conclusions:

  • Trehalose ameliorates AD-like phenotypes in a *Drosophila* model by reducing Aβarc levels.
  • Trehalose restores mitochondrial structure and function, contributing to improved motor performance.
  • These findings suggest trehalose holds promise as a therapeutic intervention for Alzheimer's disease.

Related Concept Videos

Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Energy to Drive Translocation01:37

Energy to Drive Translocation

Mitochondrial protein import is powered by two distinct energy sources: ATP hydrolysis and electrochemical potential across the inner membrane. Newly synthesized precursors are bound by cytosolic chaperones of the Hsp70 family, which guide them to the import receptors on the mitochondrial surface. Utilizing the energy of ATP hydrolysis, Hsp70 chaperones transfer these precursors to the TOM receptors on the mitochondrial outer membrane.
Generally, polypeptides are unfolded by two distinct...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...